![Stephen Fawell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Fawell
Director/Board Member at
C4 THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2026
Profile
Stephen Fawell is an Independent Director at C4 Therapeutics, Inc. starting in 2024.
Formerly, Dr. Fawell was Executive Director-Drug Discovery at Novartis Institutes for Biomedical Research, Inc. Education includes an undergraduate degree from the University of Bradford and a doctorate from the University of Leeds.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Stephen Fawell active positions
| Companies | Position | Start |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director/Board Member | 29/08/2024 |
Former positions of Stephen Fawell
| Companies | Position | End |
|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | - |
Training of Stephen Fawell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Bradford
 University of Bradford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Stephen Fawell
Choose MarketScreener 
